Status:
COMPLETED
Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery
Lead Sponsor:
The Cleveland Clinic
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary purpose of this study is to determine the best blood level to begin transfusing red blood cells in individuals undergoing cardiac surgery. The secondary aim is to determine the impact of ...
Detailed Description
Consecutive consenting patients who meet the inclusion criteria will be randomized to one of 2 transfusion groups based on their HCT value. Hematocrit Groups: 1. 24% 2. 28% Red blood cell transfusi...
Eligibility Criteria
Inclusion
- All primary and reoperative adult cardiac surgical patients undergoing cardiopulmonary bypass for coronary artery bypass grafting, coronary artery bypass grafting with a valve procedure, isolated valve procedures and ascending aortic repair for aneurysm or dissection procedures.
Exclusion
- Age less than 18 years
- Congenital procedures
- Emergencies
- descending thoracic aortic aneurysm repairs
- Left or right ventricular assist devices
- Left ventricular aneurysm resections
- Heart or lung transplantation
- Those unable to receive blood for religious reasons
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 3 2019
Estimated Enrollment :
722 Patients enrolled
Trial Details
Trial ID
NCT00651573
Start Date
March 1 2007
End Date
January 3 2019
Last Update
June 14 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195
2
S.A.L. Hospital and Medical Institute
Ahmedabad, Thaltej,, India, 380054